Birla Fertility to Invest ₹500 Crore in Expansion Over Next 2-3 Years

Birla Fertility & IVF, part of the CK Birla Group, is set to invest ₹500 crore over the next two to three years as it aims to strengthen its foothold in India’s fertility market. Currently ranked as the third-largest fertility chain in the country, the company plans to use this investment to expand its presence, particularly in the southern region, by opening 10-12 new centers across Karnataka, Tamil Nadu, Kerala, Telangana, and Andhra Pradesh within the next 12-24 months.

The strategic investment will focus on enhancing infrastructure and providing advanced fertility solutions, especially in Tier-II and Tier-III cities. This expansion aligns with Birla Fertility & IVF’s broader goal of making fertility treatments more accessible across India. The company’s recent acquisition of two fertility clinic chains, BabyScience and ARMC IVF, has significantly bolstered its network, increasing its footprint to 50 clinics nationwide.

The acquisition of BabyScience, which includes 12 clinics located in Karnataka, Maharashtra, and Tamil Nadu, has not only expanded Birla Fertility & IVF’s presence in the southern and western regions but also reinforced its position as a major player in the Indian fertility market. These strategic moves are part of the company’s larger plan to establish 100 clinics by FY28, leveraging a mix of organic growth, further acquisitions, and strategic partnerships.

By focusing on expanding into new regions and upgrading its facilities, Birla Fertility & IVF aims to capture a larger share of the growing fertility market in India. The company’s commitment to scaling its operations reflects its ambition to lead the fertility sector and provide comprehensive care to a broader demographic across the country.

This ₹500 crore investment underscores Birla Fertility & IVF’s strategic vision and dedication to growth, positioning the company for continued success in the competitive fertility industry.

News by Rahul Yelligetti